20-F: Australian Oilseeds Faces Going Concern Amid Nasdaq Delisting Threats
Annual Report
Australian Oilseeds Holdings Limited reported increased revenue but a significant decline in gross profit and operating loss, raising substantial doubt about its ability to continue as a going concern.
Summary
- Sales revenue increased by 23.64% to AUD$41.7 million for the fiscal year ended June 30, 2025, up from AUD$33.7 million in the prior year.
- Gross profit decreased by 41.48% to AUD$3.46 million in FY2025, down from AUD$5.92 million in FY2024.
- The company recorded an operating loss of AUD$323 in FY2025, a significant decline from an operating profit of AUD$2.99 million in FY2024.
- Net loss for the year significantly reduced by 93.11% to AUD$1.46 million in FY2025, compared to AUD$21.23 million in FY2024, primarily due to the absence of a large recapitalization expense from the prior year.
- Net current liabilities increased to AUD$13.06 million in FY2025 from AUD$6.97 million in FY2024.
- Cash and cash equivalents increased to AUD$2.31 million in FY2025 from AUD$0.51 million in FY2024.
- Net cash provided by operating activities was AUD$966,511 in FY2025, a positive shift from an outflow of AUD$2.18 million in FY2024.
- The company faces substantial doubt about its ability to continue as a going concern, relying on cash from operations and additional financing.
- Shareholders approved a reverse share split in the range of 1-for-2 to 1-for-8 on July 30, 2025, to address Nasdaq's minimum bid price requirement.
- Nasdaq granted an extension until September 30, 2025, for the company to regain compliance with the minimum stockholders' equity requirement of $2.5 million for The Nasdaq Capital Market.
Sentiment
Score: 2
Explanation: The company faces severe financial challenges, including recurring losses, a significant decline in gross and operating profit, increased net current liabilities, and explicit 'going concern' doubt. Multiple Nasdaq listing compliance issues, despite some resolutions, highlight ongoing instability. While revenue growth and strategic initiatives are positive, they are overshadowed by these fundamental financial and operational concerns.
Positives
- Sales revenue increased by 23.64% to AUD$41.7 million in FY2025, driven by increased sales to existing customers and expanded reach of GEO brands.
- Retail oils revenue surged by 58.4% to AUD$19.89 million, primarily due to supply contracts with major Australian supermarket chains like Costco, Woolworths, and Coles.
- High protein meals revenue increased by 18.4% to AUD$10.86 million, attributed to growing market awareness of the company's high-quality, chemical-free products.
- Net cash provided by operating activities turned positive at AUD$966,511 in FY2025, compared to a net outflow in the prior year.
- The company successfully regained compliance with Nasdaq's minimum bid price requirement on January 3, 2025, after an initial deficiency notice.
- The company filed its delinquent Quarterly Report on Form 10-Q on May 30, 2025, regaining compliance with Nasdaq's filing obligations.
- Shareholders' equity increased to AUD$4.65 million in FY2025 from AUD$0.91 million in FY2024, partly due to the conversion of a related party loan to equity.
- The company operates the largest cold pressing oil plant in Australia, with a processing capacity of over 70,000 metric tons per annum.
- Strategic initiatives include expanding into plant-based meats and proteins markets and aiming for carbon neutrality with 568-kilowatt peak solar power abating 42.2 metric tons of CO2 per month.
Negatives
- Gross profit decreased significantly by 41.48% to AUD$3.46 million in FY2025, primarily due to increased cost of inputs without a corresponding increase in sales prices.
- Operating profit turned into an operating loss of AUD$323 in FY2025, a 100% decline from the prior year's operating profit.
- Net current liabilities increased substantially to AUD$13.06 million in FY2205 from AUD$6.97 million in FY2024, indicating a deteriorating short-term liquidity position.
- Finance expenses increased by 74.2% to AUD$1.46 million in FY2025, driven by the utilization of a trade facility, convertible note amortization, and interest accrual on promissory notes.
- The company received a second Nasdaq minimum bid price deficiency notice on May 27, 2025, requiring compliance by November 24, 2025.
- The company received a Nasdaq notification on December 6, 2024, for failing to meet the minimum shareholders' equity requirement of $10 million, later granted an extension to meet $2.5 million by September 30, 2025.
- Foreign currency payments related to EDOC legacy costs increased significantly to AUD$3,013,604 in FY2025 from AUD$28,097 in FY2024, impacting finance expenses.
- The company has a history of net losses and its ability to continue as a going concern is explicitly stated as being in substantial doubt.
- Dependence on a material concentration of revenue from a small group of customers (top three customers accounted for 50.5% of accounts receivable in FY2025) poses a significant risk.
Risks
- Stock price volatility and potential for substantial losses for investors.
- Inability to maintain Nasdaq listing due to minimum bid price and shareholders' equity requirements.
- Significant influence of principal shareholders over corporate actions.
- Potential for securities class action litigation, especially following de-SPAC merger transactions.
- No expected dividends; investors must rely on share price appreciation for returns.
- Future sales of substantial amounts of ordinary shares could adversely affect market price.
- Emerging growth company status may make shares less attractive to investors.
- Anti-takeover provisions in corporate documents could impair acquisition attempts.
- Significant dependence on revenues from cold-pressed vegetable oils, making the company vulnerable to market changes in oil seeds.
- Lack of product and business diversification, increasing susceptibility to agricultural industry risks.
- Dependence on contracts with local and regional farmers for oilseeds, with risks of non-renewal or quality issues.
- Concentration of revenue from a small group of customers, with potential adverse impact from loss of any key customer.
- Exposure to global, federal, state, and local regulations, including trade restrictions, food safety, and environmental laws.
- Operations are subject to changing conditions, such as unfavorable weather (blight, bush fires, drought, flooding) and environmental factors.
- Disruptions in water and power supply could adversely affect operations and raw material access.
- Operating results may fluctuate due to demand, oil seed costs, utility costs, and plant interruptions.
- Revenue may not achieve budget in FY2026 due to capital expenditure for facility expansion and legacy cost payments affecting working capital.
- Failure to effectively promote the brand, particularly its GMO-free and chemical-free attributes, could adversely affect business.
- Inability to hire and retain qualified personnel, especially key management like Gary Seaton, could harm growth and operations.
- Exposure to claims, litigation, or regulatory actions, with potential for substantial costs and diversion of management attention.
- Retail price of products may be subject to government control, potentially reducing profitability.
- Requirement for various permits and licenses, with risks of non-compliance or inability to renew.
- Adverse publicity associated with products or raw materials could harm reputation and sales.
- Inability to develop new products could adversely affect business and financial condition.
- Operations may be disrupted for maintenance or reasons beyond control (e.g., extreme weather, equipment failures).
- Risk of improper disclosure or loss of sensitive data, including cyber-attacks.
- Geopolitical risks, including impacts on supply chain and inflation from global unrest.
- Risk of natural disasters, acts of God, and epidemics severely disrupting business operations.
- Product contamination could lead to liability claims and product recalls.
- Failure to compete effectively against more established competitors with greater resources.
- Management's limited experience in operating a public company could lead to challenges in regulatory compliance.
- Increased expenses and administrative burdens as a public company.
- Lack of research or unfavorable research from securities or industry analysts could depress share price.
- Business model is capital-intensive, with risks of not being able to raise additional capital on attractive terms, leading to dilution.
- History of net losses and substantial doubt about the ability to continue as a going concern.
- Warrants may be redeemed prior to their exercise at a time disadvantageous to warrant holders.
Future Outlook
Management believes its sources of liquidity, including cash from operations, unused Commonwealth Bank of Australia facilities (AUD$6,780,934), and potential drawdowns from US$6 million redeemable debentures or a US$50 million Equity Line Of Credit (ELOC), will be sufficient to meet financing requirements for the one-year period from the issuance of its consolidated financial statements. However, there is no assurance these sources will be sufficient long-term, and the company's ability to continue as a going concern is dependent on successfully meeting these objectives and/or raising additional funds.
Management Comments
- We are committed to working with suppliers and customers to eliminate chemicals from the edible oil production and manufacturing systems to supply quality products such as non-GMO oilseeds and organic and non-organic food-grade oils to customers globally.
- The primary driver for the revenue increase in retail oils for the year ended June 30, 2025, compared to the previous year was due to the Company supply contracts with Costco, Woolworths and Coles, which are majority of Australia's largest supermarket chains.
- The primary driver for the revenue increase in high protein meals for the year ended June 30, 2025, compared to the previous year was the market awareness of the company's high quality and chemical free concept from local farmers, wholesalers and distributors.
- The primary reason for the increase in cost of sales was due to increase in cost of inputs for manufacturing (raw material, packing cost and labour) without corresponding increase in sales price.
- The Company has determined that the Company's sources of liquidity will be sufficient to meet the Company's financing requirements for the one year period from the issuance of its consolidated financial statements but there can be no assurance these sources are sufficient to fund our capital expenditures, working capital and other cash requirements in the long term. There can be no assurance that the steps management is taking will be successful.
Industry Context
The company operates in the global oilseeds industry, which is experiencing increasing demand for healthy, chemical-free, non-GMO, and sustainable edible oils and plant-based proteins. Australia's oilseed production is well-positioned to supply rapidly expanding consumer export markets in Asia-Pacific and meet domestic demands. The company's strategy aligns with this trend by focusing on cold-pressed, non-GMO products and leveraging protein meal by-products for plant-based meat markets. The industry also faces challenges from volatile commodity prices, climate-related conditions, and evolving food safety regulations.
Comparison to Industry Standards
- The company's Cootamundra facility, with a processing capacity of over 70,000 metric tons per annum, is positioned as the largest cold pressing oil plant in Australia, indicating a significant scale within its niche.
- The company's commitment to chemical-free, non-GMO, and sustainable edible oils, along with regenerative farming practices, aligns with growing consumer demand for healthier and environmentally conscious food products, potentially differentiating it from conventional oilseed processors.
- The partial adoption of renewable solar energy (568-kilowatt peak solar power, abating 42.2 metric tons of CO2 per month) and the aim for carbon neutrality positions the company favorably against industry peers in terms of environmental sustainability, aligning with UN Sustainable Development Goals.
- The expansion into plant-based meats and proteins markets leverages a by-product, indicating an adaptive strategy to capitalize on emerging food industry trends, similar to how other agricultural processors are diversifying their product portfolios.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Financial Officer | Bob Wu | Amarjeet Singh | February 28, 2025 | Bob Wu resigned in February 2025; Amarjeet Singh appointed. |
| Director (Independent), Nomination Committee Chair | NA | Phaneesh Murthy | May 1, 2025 | Elected to the Board of Directors at the April 2025 Annual Meeting of shareholders. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Policy Adoption | Adopted a compensation clawback policy requiring the company to clawback erroneously awarded incentive compensation from current and former executive officers under certain conditions. | April 10, 2024 | Enhances accountability and aligns executive compensation with financial reporting accuracy, potentially reducing risk of financial misstatements. |
| Policy Adoption | Adopted an Insider Trading Policy prohibiting executive officers and directors from engaging in short sales, put/call options, and hedging transactions involving company securities. | NA | Aims to prevent speculative trading and potential conflicts of interest, promoting market integrity and investor confidence. |
| Committee Composition | Phaneesh Murthy was elected to the Board and is anticipated to serve as Chair of the Nominating and Corporate Governance Committee and on the Audit Committee. | May 1, 2025 | Brings nearly four decades of industry leadership and consulting experience to enhance strategic oversight and governance, particularly in technology and business services. |
| Committee Composition | Gowri Shankar qualifies as an audit committee financial expert and serves as Chair of the Audit Committee. | NA | Ensures specialized financial expertise in overseeing financial reporting, internal controls, and audit functions, strengthening financial oversight. |
| Controlled Company Status | The company is a controlled company as its CEO and founder, Gary Seaton, beneficially owns more than 50% of the voting power. It does not intend to rely on associated Nasdaq exemptions initially but may elect to. | NA | Provides flexibility in corporate governance structure but may reduce certain shareholder protections typically afforded by independent board majorities and committees. |
Legal Proceedings
- The company is not currently a party to any legal proceedings whose outcome would individually or in the aggregate have a material adverse effect on its business or financial condition.
- The company acknowledges the general risk of securities class action litigation, particularly against companies following a decline in market price or related to de-SPAC merger transactions, which could result in substantial costs and diversion of management attention.
Related Party Transactions
- Energreen Nutrition Australia Pty Ltd (controlled by CEO Gary Seaton) is a key related party, involved in significant purchases of seed (AUD$14,376,490 in FY2025) and sales of meals (AUD$5,818,454 in FY2025), and provides supply-chain support for raw materials.
- A related party loan amounting to AUD$4,998,512 owed to JSKS Enterprises Pty Ltd (100% owned by CEO Gary Seaton) was converted into equity shares during FY2025.
- The company has outstanding promissory notes to American Physicians, LLC, totaling AUD$1,538,322 as of June 30, 2025, with specific payment schedules extending into December 2025.
- Soon Soon Oilmills Sdn Bhd (20% owned by CEO Gary Seaton) is a related party involved in purchases of oils (AUD$699,200 in FY2025).
- Sunmania Pty Ltd is a related party involved in other sales (AUD$32,868 in FY2025) and lease arrangements (AUD$77,000 in FY2025).
- CQ Oilseeds Pty Ltd, currently owned by Energreen Nutrition, is expected to become a wholly-owned subsidiary of the company in the future, with its equity interest to be transferred.
Stakeholder Impact
- **Shareholders:** Face significant risks due to stock price volatility, potential delisting from Nasdaq, and the company's 'going concern' doubt. The approved reverse share split aims to address bid price compliance but could impact share liquidity and perception. No dividends are expected in the foreseeable future.
- **Employees:** The company has 24 full-time employees and 8 full-time equivalent contractors, with management believing relationships are cooperative. The ability to hire and retain qualified personnel is crucial for growth, and loss of key personnel could adversely affect the business.
- **Customers:** The company's dependence on a small group of key customers (top three accounted for 50.5% of receivables) means loss of any could severely impact revenue and profitability. The focus on chemical-free, non-GMO products caters to a growing consumer demand for healthy oils.
- **Suppliers:** The company relies on contracts with local and regional farmers for oilseeds, and the loss or quality issues from these contracts could materially affect operations. Related party suppliers like Energreen Nutrition Australia Pty Ltd are critical to the supply chain.
- **Creditors:** The company's net current liability position and 'going concern' doubt indicate increased risk for creditors. The company relies on additional long-term debt and capital raises to meet its financial obligations.
Next Steps
- Regain compliance with Nasdaq's minimum bid price requirement ($1.00 per share) by November 24, 2025, potentially through a reverse stock split.
- Demonstrate compliance with Nasdaq's minimum stockholders' equity requirement ($2.5 million) by September 30, 2025.
- Generate sufficient cash flows from business operations to address going concern doubts.
- Draw down additional long-term debt from Commonwealth Bank of Australia (AUD$6,780,934 unused facility).
- Draw down an additional US$6 million of redeemable debentures from existing PIPE investors.
- Lodge the registration statement for the US$50 million Equity Line Of Credit (ELOC) and utilize it for funding.
- Continue to expand the Cootamundra facility for increased capacity.
- Manage cash flows towards payment of outstanding legacy costs and promissory notes.
- Review the Securities Purchase Agreement regarding Arena's withdrawal of USD$1 million from an Escrow account to confirm its impact on outstanding convertible notes.
Key Dates
| Date | Description |
|---|---|
| 2022-12-29 | Australian Oilseeds Holdings Limited incorporated in the Cayman Islands. |
| 2023-01-01 | Commencement of Cootamundra land lease term. |
| 2023-08-23 | Securities Purchase Agreement signed between the Company, AOI, EDOC, certain AOI subsidiaries and Arena Investors, LP. |
| 2023-10-31 | Amendment No. 1 to Securities Purchase Agreement signed. |
| 2023-12-04 | Amendment No. 2 to Securities Purchase Agreement signed. |
| 2024-02-14 | Company drew down an equipment loan of AUD$4,000,000 with Commonwealth Bank of Australia. |
| 2024-02-29 | Amendment No. 3 to the Securities Purchase Agreement entered. |
| 2024-03-21 | Consummation of the Business Combination (deSPAC) with EDOC Acquisition Limited; Company issued two promissory notes to American Physicians, LLC. |
| 2024-03-22 | Ordinary Shares and PubCo Warrants commenced trading on Nasdaq Capital Market. |
| 2024-04-10 | Board of Directors adopted a compensation clawback policy. |
| 2024-05-19 | First quarterly payment for the Secured Bank Loan commenced. |
| 2024-06-01 | Company entered into a payment agreement with Ellenoff Grossman & Schole LLP (EGS) for legal fees related to the Business Combination. |
| 2024-08-28 | Received Nasdaq notification of non-compliance with minimum bid price requirement ($1 per share). |
| 2024-12-06 | Received Nasdaq notification of non-compliance with minimum shareholders' equity requirement ($10,000,000). |
| 2025-01-03 | Nasdaq confirmed the company regained compliance with the minimum bid price requirement. |
| 2025-01-20 | Company submitted its plan to regain compliance with Nasdaq's shareholders' equity requirement. |
| 2025-02-18 | Nasdaq granted an extension to May 30, 2025, to regain compliance with the shareholders' equity rule. |
| 2025-02-28 | Amarjeet Singh appointed as Group Chief Financial Officer. |
| 2025-05-01 | Phaneesh Murthy elected to the Board of Directors. |
| 2025-05-27 | Received a second Nasdaq notification of non-compliance with the minimum bid price requirement ($1 per share), with 180 calendar days to regain compliance by November 24, 2025. |
| 2025-05-27 | Received Nasdaq notification for delinquent filing of Quarterly Report on Form 10-Q for the period ended March 31, 2025. |
| 2025-05-30 | Filed Quarterly Report on Form 10-Q for the period ended March 31, 2025, regaining compliance with filing obligations. |
| 2025-06-21 | First payment of USD$165,000 plus accrued interest due for the Second Promissory Note to American Physicians, LLC. |
| 2025-06-30 | End of fiscal year 2025. |
| 2025-07-10 | Company received conversion notice from Arena (PIPE) for USD$250,000 of convertible debt to 420,066 Class A Ordinary shares. |
| 2025-07-22 | Nasdaq Hearings Panel granted an extension to September 30, 2025, to regain compliance with the Equity Rule ($2.5 million minimum). |
| 2025-07-30 | Shareholders approved a reverse share split (1-for-2 to 1-for-8 ratio) at an extraordinary general meeting. |
| 2025-08-22 | Nasdaq granted continued listing subject to demonstrating compliance with the equity rule by September 30, 2025. |
| 2025-09-21 | Second payment of USD$165,000 plus accrued interest due for the Second Promissory Note to American Physicians, LLC. |
| 2025-10-23 | Date of filing of this 20-F Annual Report. |
| 2025-11-24 | Deadline to regain compliance with Nasdaq's minimum bid price requirement (from May 27, 2025 notice). |
| 2025-12-21 | Remaining balance plus accrued interest due for the Second Promissory Note to American Physicians, LLC. |
| 2025-12-31 | End of Cootamundra land lease term. |
| 2029-03-21 | Expiration date of Public, Private, and Representative Warrants. |
| 2035-12-31 | End of solar power system lease term. |
Recommendation
strong sellThe company faces severe financial distress, evidenced by a significant decline in gross profit (down 41.48%) and a shift from operating profit to an operating loss in FY2025. Despite a reduction in net loss, this was primarily due to the absence of a one-time recapitalization expense, not improved operational performance. The explicit 'substantial doubt about the Company's ability to continue as a going concern,' coupled with a worsening net current liability position (increasing to AUD$13.06 million), indicates precarious financial health. Furthermore, the company is grappling with multiple, recurring Nasdaq listing compliance issues, including minimum bid price and shareholders' equity deficiencies, which pose an imminent delisting threat. While revenue growth and strategic initiatives are present, the fundamental operational and liquidity challenges, along with the high risk of delisting, make this a high-risk investment. A seasoned investor would likely prioritize capital preservation and exit this position.
Keywords
Oilseeds, Cold Pressing, Edible Oils, Protein Meals, GMO-Free, Sustainable Agriculture, Nasdaq Listing, Going Concern, Financial Performance, SEC Filing, Australia, Agricultural Products, Plant-Based Proteins, Corporate Governance, Risk Management, Capital Raise, Warrants
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.